Rwanda’s Strategic Initiative to Export Human Plasma

Rwanda is putting in place modalities to export human plasma to contracted firms, for purposes of producing plasma derived medicinal products (PDMPs). PDMPs are prepared industrially from human plasma by pharmaceutical manufacturers and include products such as immunoglobulins, coagulation factors and albumin, which are life-saving therapies for several chronic and acute life-threatening diseases such as hemophilia […]